摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3S)-1-<<(2-methylpropyl)carbonyl>amino>-2-hydroxy-3-<(tert-butyloxycarbonyl)amino>-5-methylhexane | 108868-56-0

中文名称
——
中文别名
——
英文名称
(2S,3S)-1-<<(2-methylpropyl)carbonyl>amino>-2-hydroxy-3-<(tert-butyloxycarbonyl)amino>-5-methylhexane
英文别名
tert-butyl N-[(2S,3S)-2-hydroxy-5-methyl-1-(3-methylbutanoylamino)hexan-3-yl]carbamate
(2S,3S)-1-<<(2-methylpropyl)carbonyl>amino>-2-hydroxy-3-<(tert-butyloxycarbonyl)amino>-5-methylhexane化学式
CAS
108868-56-0
化学式
C17H34N2O4
mdl
——
分子量
330.468
InChiKey
SYHPZCCRNLXQRW-KBPBESRZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    23
  • 可旋转键数:
    10
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    87.7
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    (2S,3S)-1-<<(2-methylpropyl)carbonyl>amino>-2-hydroxy-3-<(tert-butyloxycarbonyl)amino>-5-methylhexane盐酸 作用下, 以 1,4-二氧六环 为溶剂, 生成 N-((2S,3S)-3-Amino-2-hydroxy-5-methyl-hexyl)-3-methyl-butyramide
    参考文献:
    名称:
    Novel renin inhibitors containing analogs of statine retro-inverted at the C-termini. Specificity at the P2 histidine site
    摘要:
    Substituted 1,3- and 1,4-diamines were prepared from epoxides derived from Boc-leucine or Boc-cyclohexylalanine. These diamines were incorporated into renin inhibitors (IC50 = 4-1500 nM) replacing the Leu-Val scissile bond in small peptide analogues of angiotensinogen. Replacement of the P2 histidine imidazole with other heterocycles maintained or enhanced binding while changing the overall basicity of the inhibitor. Finally, substitution of O-methyltyrosine for the P3 phenylalanine suppressed chymotrypsin cleavage of the P3-P2 bond.
    DOI:
    10.1021/jm00390a018
  • 作为产物:
    描述:
    (2S,3S)-1-amino-2-hydroxy-3-<(tert-butyloxycarbonyl)amino>-5-methylhexane acetic acid salt 、 异戊酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以90%的产率得到(2S,3S)-1-<<(2-methylpropyl)carbonyl>amino>-2-hydroxy-3-<(tert-butyloxycarbonyl)amino>-5-methylhexane
    参考文献:
    名称:
    Novel renin inhibitors containing analogs of statine retro-inverted at the C-termini. Specificity at the P2 histidine site
    摘要:
    Substituted 1,3- and 1,4-diamines were prepared from epoxides derived from Boc-leucine or Boc-cyclohexylalanine. These diamines were incorporated into renin inhibitors (IC50 = 4-1500 nM) replacing the Leu-Val scissile bond in small peptide analogues of angiotensinogen. Replacement of the P2 histidine imidazole with other heterocycles maintained or enhanced binding while changing the overall basicity of the inhibitor. Finally, substitution of O-methyltyrosine for the P3 phenylalanine suppressed chymotrypsin cleavage of the P3-P2 bond.
    DOI:
    10.1021/jm00390a018
点击查看最新优质反应信息

文献信息

  • PEPTIDE ANALOGS
    申请人:DELLARIA, Joseph
    公开号:EP0258289A1
    公开(公告)日:1988-03-09
  • EP0258289A4
    申请人:——
    公开号:EP0258289A4
    公开(公告)日:1991-01-02
  • [EN] PEPTIDE ANALOGS
    申请人:DELLARIA, Joseph
    公开号:WO1987004349A1
    公开(公告)日:1987-07-30
    (EN) A genus of novel peptide analogs which have potent renin-inhibiting activity, methods of treating renin-based hypertension using these compounds, and pharmaceutical compositions containing these compounds as active ingredients.(FR) Est décrit un genre de nouveaux analogues de peptides qui possèdent une puissante activité d'inhibition de la rénine, des procédés de traitement de l'hypertension causée par la rénine au moyen de ces composés, et des compositions pharmaceutiques renfermant ces composés comme principes actifs.
  • Novel renin inhibitors containing analogs of statine retro-inverted at the C-termini. Specificity at the P2 histidine site
    作者:Saul H. Rosenberg、Jacob J. Plattner、Keith W. Woods、Herman H. Stein、Patrick A. Marcotte、Jerome Cohen、Thomas J. Perun
    DOI:10.1021/jm00390a018
    日期:1987.7
    Substituted 1,3- and 1,4-diamines were prepared from epoxides derived from Boc-leucine or Boc-cyclohexylalanine. These diamines were incorporated into renin inhibitors (IC50 = 4-1500 nM) replacing the Leu-Val scissile bond in small peptide analogues of angiotensinogen. Replacement of the P2 histidine imidazole with other heterocycles maintained or enhanced binding while changing the overall basicity of the inhibitor. Finally, substitution of O-methyltyrosine for the P3 phenylalanine suppressed chymotrypsin cleavage of the P3-P2 bond.
查看更多